Back to Blog
General Guidance

Section 108 Passed the House. The Text Reaches Claims Filed Since October 1, 2026.

Editorial Team
November 17, 2026
22 min read
Section 108 Passed the House. The Text Reaches Claims Filed Since October 1, 2026.

Section 108 of the Take Care of America's Veterans Act would revise the VA rating criteria for sleep apnea and tinnitus. The House passed the bill on November 11, 2026. As passed, Section 108(c)(1) applies the revised criteria to claims filed on or after October 1, 2026, a date that precedes the vote. Section 108(c)(2) separately bars using the revisions to reduce compensation already in effect the day before enactment. The bill is not law. It awaits Senate action.

Summary

  • The House passed H.R. 9237 by voice vote on November 11, 2026. A motion to reconsider was laid on the table, so the House action is final. The Senate has taken no floor action.

  • The applicability date changed during House consideration. The bill as introduced read "claims filed after the date of the enactment of this Act." The adopted amendment struck that phrase and inserted "on or after October 1, 2026."

  • The protection clause was not amended. It still refers to compensation in effect the day before enactment. The two subsections therefore run from different dates.

  • Veterans already receiving compensation for sleep apnea or tinnitus are protected from reduction on the basis of these revisions.

  • Nothing has changed yet. VA continues to rate both conditions under the current criteria, and the revised criteria would have to be promulgated before they could be applied.

Coverage of the November 11 vote has been uneven on one point that matters more than any other. Some of it states that Section 108 would reach only future claims, and some advises veterans to file quickly in order to stay ahead of the change. Read against the text the House actually passed, neither statement is reliable.

What follows is drawn from the congressional documents themselves. Because the operative date was altered in a self-executing amendment rather than in the bill as introduced, the derivation is set out in full below, so that any reader can confirm it independently.

What the House did on November 11

H.R. 9237 was introduced on June 10, 2026 by House Veterans' Affairs Committee Chairman Mike Bost, with a Senate companion, S. 4744, introduced the same day by Senate Veterans' Affairs Committee Chairman Jerry Moran. The package assembles more than 60 previously introduced veterans bills. Section 101 contains the Major Richard Star Act, which would end the offset reducing retired pay for combat-injured Chapter 61 retirees.

Consideration was interrupted twice. On July 16, 2026, after one hour of debate, a motion to recommit offered by Rep. Deluzio failed 210 to 211, and the Chair announced that further proceedings were postponed. The measure returned on November 11, Veterans Day, when the House resumed consideration as unfinished business and passed the bill by voice vote, without a recorded tally. A motion to reconsider was laid on the table without objection.

The circumstances have themselves become a subject of dispute. Reporting indicates that Democratic leaders, including Ranking Member Mark Takano, were off the floor at the Rules Committee when the voice vote was called. The VFW issued a statement condemning the manner of passage. The following day, November 12, the House passed a standalone version of the Major Richard Star Act by 392 to 18, financed without the Section 108 offset.

How we know what the passed text says

As of this writing, the engrossed text of H.R. 9237 has not been published. The text as passed can nonetheless be established with certainty, because the House adopted a single self-executing amendment and that amendment is published. The derivation runs as follows.

  1. The bill as introduced states at Section 108(c)(1) that the revisions "shall apply with respect to claims filed after the date of the enactment of this Act." That sentence appears at printed page 61, line 5.H.R. 9237, Introduced in House, June 10, 2026, page 61

  2. H. Res. 1423 provided for consideration under a closed rule and deemed adopted the amendment printed in part B of the accompanying Rules Committee report.H. Res. 1423, agreed to July 14, 2026 by 215 to 211

  3. The House record shows H.Amdt. 240 considered as adopted, described as the amendment printed in part B of Report 119-749.Congress.gov amendment record for H.R. 9237

  4. Part B of that report contains more than 180 separate amendment instructions. Exactly one touches Section 108. It reads: "Page 61, line 5, strike ''after the date of the enactment of this Act'' and insert ''on or after October 1, 2026''."House Report 119-749, part B

  5. No instruction in part B reaches page 61, lines 7 through 12, which contain Section 108(c)(2). The next instruction in sequence addresses page 63. The protection clause is therefore unamended.House Report 119-749, part B

Applying that single instruction to the introduced text produces the operative language:

(c) APPLICABILITY.—(1) IN GENERAL.—The revisions to the schedule for rating disabilities adopted and applied under section 1155 of title 38, United States Code, made pursuant to this section shall apply with respect to claims filed on or after October 1, 2026.

(2) PROTECTION OF EXISTING RATINGS.—The revisions to the schedule for rating disabilities made pursuant to this section may not serve as the basis for reducing, discontinuing, or otherwise adversely affecting compensation that was in effect on the day before the date of the enactment of this Act.

Section 108(c), H.R. 9237 as passed by the House, November 11, 2026

One further detail is worth recording. In part B, the instruction amending the applicability date sits between an instruction correcting "processors" to "processor" at page 58 and an instruction inserting the words "the day that is" at page 63. The surrounding instructions in that run are grammatical and typographical corrections. We state the placement as a matter of record and draw no conclusion about intent.

What Section 108 would change

Subsections (a) and (b) were not amended in part B. They passed as introduced.

Sleep apnea

Sleep apnea is currently evaluated under 38 C.F.R. § 4.97, Diagnostic Code 6847, which covers obstructive, central, and mixed sleep apnea syndromes. The present scale is 0, 30, 50, and 100 percent, and the 50 percent evaluation attaches where the condition requires use of a breathing assistance device such as a CPAP machine. In practice the prescription carries much of the evaluative weight.

Section 108(a) directs the Secretary to substitute four grades keyed to treatment response. A syndrome that is asymptomatic, with or without treatment, receives 0 percent. Treatment that yields incomplete relief receives 10 percent. The 50 percent grade requires that treatment be either ineffective or unusable by the veteran because of comorbid conditions, with no end-organ damage present. The 100 percent grade requires end-organ damage. No 30 percent grade appears in the new scale.

The provision defines the comorbid-condition route narrowly. A qualifying comorbid condition is one that, in the opinion of a qualified medical provider, directly impedes or prevents the use or implementation of a recognized form of treatment intervention normally shown to be effective.

Tinnitus

Recurrent tinnitus currently receives a single 10 percent evaluation under 38 C.F.R. § 4.87, Diagnostic Code 6260, whether the sound is perceived in one ear, both ears, or the head. It is the most prevalent service-connected disability in the VA system. Published figures drawn from the Veterans Benefits Administration's Annual Benefits Report for Fiscal Year 2025 put the number of affected veterans at roughly 3.5 million.

Section 108(b) provides that tinnitus may not be assigned a separate compensable disability rating, subject to one exception. A 10 percent grade is assigned where tinnitus is diagnosed as associated with service-connected hearing loss that is otherwise noncompensable.

Condition

Criteria in effect today

Section 108 as passed

Sleep apnea
DC 6847

0, 30, 50, 100. The 50 percent level attaches to required use of a breathing assistance device such as CPAP.

0, 10, 50, 100. Asymptomatic at 0. Incomplete relief on treatment at 10. Treatment ineffective or unusable due to comorbid conditions, without end-organ damage, at 50. With end-organ damage at 100.

Tinnitus
DC 6260

Single 10 percent evaluation for recurrent tinnitus in one ear, both ears, or the head.

No separate compensable rating, except 10 percent where associated with service-connected hearing loss that is otherwise noncompensable.

The two dates, and the space between them

This is the part of Section 108 that has gone largely unexamined, and it is the part most likely to affect a particular veteran.

Subsection (c)(1) reaches claims by reference to filing date, and that date is now October 1, 2026. Subsection (c)(2) protects compensation by reference to enactment. Those are different events, and between them lies a category of claim that is covered by the new criteria while falling outside the protection.

A further sequencing point matters here. Enactment alone would not change any rating, because Section 108 directs the Secretary to revise the rating schedule and the revised criteria would have to be promulgated before VA could apply them. The question for any individual claim is therefore whether it is still pending when revised criteria take effect.

The table below sets out how the two subsections read against four common situations. The entries describe what the text appears to require, not determinations VA has made. No implementing guidance exists, because the provision is not law.

Situation

Reached by (c)(1)?

Protected by (c)(2)?

Already rated and receiving compensation for sleep apnea or tinnitus

No. No new claim filed.

Yes. Compensation in effect.

Claim filed before October 1, 2026, still pending

No. Filed before the date.

Not needed on these facts.

Claim filed on or after October 1, 2026, granted and paying before enactment

Yes, by filing date.

Yes, once compensation is in effect.

Claim filed on or after October 1, 2026, still pending when revised criteria take effect

Yes, by filing date.

No compensation yet in effect to protect.

The fourth row is the gap. A veteran who filed a sleep apnea or tinnitus claim in October or November of 2026, before this legislation had passed either chamber, and whose claim is still in the queue when revised criteria arrive, would on the face of the text have that claim evaluated under the new criteria. Given ordinary VA processing times, and given that enactment would be followed by rulemaking rather than immediate effect, that is not a remote scenario.

Two things follow, and both cut against advice currently circulating. Filing quickly does not move a claim outside Section 108, because the applicability date is October 1, 2026 and has already passed. And a claim filed before the bill existed is not automatically safe, because the provision turns on the filing date rather than on whether the law was in force when the veteran filed. Read this as a correction to the claim that speed defeats Section 108, and not as a reason to delay. Filing promptly still protects the effective date that determines back pay, and against VA's separate rulemaking, where no final rule has issued, a claim filed now is still evaluated under the current criteria. Nothing in this article is a reason to postpone a supported claim.

A word on what this analysis is and is not. It is a reading of statutory text, offered for general education. It is not legal advice, it is not an opinion about any individual claim, and Military Disability Nexus is not accredited to represent claimants before VA. A veteran whose own filing date falls near October 1, 2026 should take that question to an accredited representative rather than act on this article.

We want to be careful about how far this reading is pressed. It is a reading of the text as passed by one chamber. The bill is not law, the Senate may amend or reject it, and if it were enacted, VA implementation guidance would govern how pending claims are handled in practice. What the text does not do is supply the reassurance that a quickly filed claim is unaffected.

What remains protected

Veterans already receiving compensation for sleep apnea or tinnitus should understand that several protections operate here, and that they are independent of this bill.

Section 108(c)(2) itself bars using the revisions to reduce, discontinue, or otherwise adversely affect compensation in effect the day before enactment. A second protection operates at the statutory level and deserves more attention than it has received. Title 38 U.S.C. § 1155, which is the authority for the rating schedule, provides that in no event shall a readjustment in the rating schedule cause a veteran's disability rating to be reduced unless an improvement in the veteran's disability is shown to have occurred. That matters here for a specific reason. Section 108 directs the Secretary to revise the schedule adopted and applied under section 1155, so the non-reduction rule sits inside the same statutory provision the section invokes. Its regulatory counterpart, 38 C.F.R. § 3.951(a), provides that a readjustment to the rating schedule is not grounds for reducing an evaluation already in effect unless medical evidence establishes that the disability has actually improved. An evaluation continuously rated at or above a given level for 20 years or more may not be reduced below that level except on a showing that the rating was based on fraud, under § 3.951(b). The 20-year period runs from the effective date of the evaluation to the effective date of the reduction. Service connection in effect for 10 years or more is protected from severance on comparable terms by § 3.957.

These protections are directed at reduction on the basis of a schedule change. They do not make an evaluation permanent. Reduction on other grounds continues to operate, and the safeguards are narrower than they are sometimes described. The stabilization protections of 38 C.F.R. § 3.344(a) and (b), which bar reduction on a less complete examination or a single examination in conditions subject to episodic improvement, apply under § 3.344(c) to evaluations that have continued at the same level for long periods, which the regulation defines as five years or more. By its own terms § 3.344(c) does not extend those protections to disabilities that have not stabilized and are likely to improve. Separately, and without regard to how long an evaluation has been held, § 3.105(e) requires VA to prepare a rating proposing the reduction, notify the beneficiary with the reasons, and allow 60 days to submit evidence that compensation should continue at its present level. Under § 3.105(i) the beneficiary may request a predetermination hearing within 30 days, and where one is timely requested, payments continue at the previously established level until a final determination is made. Nothing in Section 108 alters eligibility for VA health care, including sleep studies, CPAP equipment and supplies, and audiology care.

Questions the text does not answer

Several elements of Section 108 are undefined and would be resolved, if at all, through the rulemaking the provision directs. Confident assertions about any of them should be read as predictions.

The 100 percent grade turns on the presence of end-organ damage, and the provision does not define the term. Whether it would reach pulmonary hypertension, cor pulmonale, refractory hypertension, cardiac arrhythmia, or other sequelae is not stated.

The 50 percent grade turns in part on the opinion of a qualified medical provider, and that phrase is likewise undefined. Whether a private treating physician, a specialist in sleep medicine, or only a VA or contract examiner would satisfy it is unresolved.

Section 108 sets no deadline for the Secretary to revise the schedule. We searched the section for any such requirement and found none.

Finally, Section 108(c)(1) turns on when a claim is "filed," and the provision neither defines that term nor addresses an intent to file. Existing regulation bears on the question. Under 38 C.F.R. § 3.155(b), where a complete application is received within one year of an intent to file, VA considers the complete claim filed as of the date the intent to file was received. Read with that regulation, an intent to file received before October 1, 2026 and followed by a complete claim within the year would arguably place the claim outside Section 108(c)(1), because the claim would be treated as filed before the applicability date. Section 108 does not address the point, and whether VA would apply § 3.155(b) when implementing a statute that uses the word "filed" without defining it is unresolved. A veteran holding an intent to file dated before October 1, 2026 should raise it with an accredited representative rather than assume either answer, and should not treat the argument above as settled or as a basis for action.

The separate VA rulemaking track

Section 108 is one of two routes to the same destination, and conflating them accounts for much of the confusion in circulation.

In February 2022, VA published proposed rules revising the ear, nose, throat, audiology, and respiratory portions of the rating schedule, covering these same two conditions. VA told a House subcommittee in January 2026 that it anticipated publishing final rules for the four remaining body systems by the close of fiscal year 2026. That target passed. No final rule has been published, and VA's most recent regulatory agenda projects final action on the relevant rulemaking, RIN 2900-AQ72, in April 2027. The current rating schedule bears this out. In the eCFR, Diagnostic Code 6847 carries an amendment history ending at 71 FR 28586 in May 2006, and Diagnostic Code 6260 ends at 68 FR 25823 in May 2003. Neither has been revised since.

The practical distinction is this. Against the regulatory track, filing before a final rule takes effect does preserve the current criteria, which is the ordinary rule for claims. Against Section 108, filing does not help, because the statutory date has already passed. Our earlier analysis of the regulatory proposal is here: The Proposed VA Sleep Apnea Rating Change: What It Means for Your 50%.

What this means for the evidence in a claim file

Setting the legislative dispute aside, both tracks move the evaluation in the same direction. Each shifts it away from the presence of treatment and toward the response to treatment. That changes what a claim must establish.

Under Diagnostic Code 6847 as it stands, a CPAP prescription performs much of the work. Under Section 108 the prescription would establish only that the veteran is under treatment. Three separate clinical questions would then determine the grade: whether the condition is asymptomatic on treatment, whether treatment yields incomplete relief, and whether treatment is ineffective or cannot be used because of a comorbid condition.

Residual symptoms during adherent CPAP therapy are a well-characterized clinical entity rather than an unusual presentation. In a retrospective analysis of 4,853 patients from the European Sleep Apnea Database, an Epworth Sleepiness Scale score above 10 was present in 56 percent of patients at baseline and in 28.2 percent at follow-up on CPAP.[1] Review estimates place residual excessive daytime sleepiness at roughly 9 to 22 percent of CPAP-treated patients once other contributors have been accounted for, including depression, coexisting sleep disorders, medication effects, and insufficient sleep duration.[2]

Under the proposed criteria, that population would be documenting the 10 percent grade described as incomplete relief. It is worth being plain about this, because some commentary has suggested that residual symptoms would support a higher grade. On the text, they would not. The higher grades require that treatment be ineffective or unusable, which is a different clinical question from how much symptom burden remains during effective treatment.

What the record would need to show

  • Adherence data. Machine download reflecting nightly usage hours and residual AHI. Without it an examiner cannot distinguish ineffective treatment from unused treatment.

  • Objective treatment response. A post-treatment sleep study or titration data establishing whether relief is complete, incomplete, or absent, which is the distinction the grades turn on.

  • A validated symptom measure recorded over time, such as Epworth Sleepiness Scale scores in the treatment record, rather than a narrative notation that the veteran remains fatigued.

  • Alternative contributors considered and either ruled in or excluded, since each otherwise supplies a basis for attributing symptoms elsewhere.

  • Where the comorbid-condition route is at issue, identification of the specific condition together with a reasoned clinical opinion addressing how it impedes or prevents use of the prescribed treatment.

For tinnitus, the corresponding shift would tie evaluation to the ear pathology it accompanies, which raises rather than lowers the importance of the audiologic workup and the documented mechanism of injury. That holds even where the audiogram returns within normal limits, a situation we address in Tinnitus With a Normal Audiogram: Why the VA Denies It.

Military Disability Nexus produces medical evidence. We are not accredited to represent claimants before VA, and several of the questions raised above are legal rather than clinical. Whether to file, whether a pending claim should be supplemented, and which review lane to use after a denial are decisions for an accredited representative. Accredited veterans service organization representatives generally assist at no charge, and VA's Office of General Counsel maintains a searchable public directory of accredited representatives, agents, and attorneys.

On review lanes specifically, note that 38 U.S.C. § 5108 is captioned "Supplemental claims" and requires readjudication where new and relevant evidence is presented, while § 5104B provides that a claimant may request review of an existing decision of the agency of original jurisdiction and limits the evidentiary record before the higher-level adjudicator to the evidence already of record. A supplemental claim is therefore a claim, and a higher-level review is a review of a decision already made. If Section 108 were enacted, that distinction could matter. We discuss the lanes in VA Denied Your Claim Without Reviewing Your Evidence?

Military Disability Nexus produces medical evidence. We are not accredited to represent claimants before VA, and several of the questions raised above are legal rather than clinical. Whether to file, whether a pending claim should be supplemented, and which review lane to use after a denial are decisions for an accredited representative. Accredited veterans service organization representatives generally assist at no charge, and VA's Office of General Counsel maintains a searchable public directory of accredited representatives, agents, and attorneys.

On review lanes specifically, note that 38 U.S.C. § 5108 is captioned "Supplemental claims" and requires readjudication where new and relevant evidence is presented, while § 5104B provides that a claimant may request review of an existing decision of the agency of original jurisdiction and limits the evidentiary record before the higher-level adjudicator to the evidence already of record. A supplemental claim is therefore a claim, and a higher-level review is a review of a decision already made. If Section 108 were enacted, that distinction could matter. We discuss the lanes in VA Denied Your Claim Without Reviewing Your Evidence?

What an evidence file built for a treatment-response standard contains

  • Forensic review of the complete medical and service record rather than a summary of the veteran's account

  • Rationale drafted to the language of the applicable Diagnostic Code

  • Treatment-response documentation resting on objective data and validated instruments

  • Alternative explanations addressed affirmatively, so that they cannot be used to discount the claim

  • Peer-reviewed literature supporting each mechanism advanced

  • Effective-date documentation preserved throughout

  • Drafting prepared with Board of Veterans' Appeals review in mind, not the rating board alone

The $200 template letter

  • Unnamed clinician with no specialty match

  • Copy-paste rationale, no record review

  • Restates the diagnosis and stops there

  • Never engages the criteria language

  • Assigned minimal probative weight

A clinician-led medical opinion

  • Named, licensed, specialty-matched physician

  • Full record review with a documented timeline

  • Impairment measured against the criteria

  • Contrary evidence answered directly

  • Prepared with appellate review in view

A denial carries a cost measured in months or years of foregone back pay, and in some cases a benefit the veteran never recovers. Measured against that, developing the evidence correctly at the outset is the smaller figure.

Sources and citations

  1. Bonsignore MR, Pepin JL, Cibella F, Barbera CD, Marrone O, Verbraecken J, et al. Excessive Daytime Sleepiness in Obstructive Sleep Apnea Patients Treated With Continuous Positive Airway Pressure: Data From the European Sleep Apnea Database. Front Neurol. 2021;12:690008. doi:10.3389/fneur.2021.690008

  2. Rosenberg R, Schweitzer PK, Steier J, Pepin JL. Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management. Postgrad Med. 2021;133(7):772–783. doi:10.1080/00325481.2021.1948305

  3. H.R. 9237, Take Care of America's Veterans Act, § 108, 119th Cong. (Introduced in House, June 10, 2026), page 61. U.S. Government Publishing Office.

  4. H. Rept. 119-749, part B (amendment considered as adopted, H.Amdt. 240). U.S. Government Publishing Office.

  5. H. Res. 1423, 119th Cong. (agreed to July 14, 2026). Congress.gov. Office of the Clerk, U.S. House of Representatives, Roll Call 249 (July 16, 2026).

  6. Congress.gov legislative action record for H.R. 9237, including passage by voice vote on November 11, 2026 and motion to reconsider laid on the table.

  7. Veterans Benefits Administration, Annual Benefits Report, Fiscal Year 2025.

  8. Electronic Code of Federal Regulations: 38 C.F.R. § 4.97 (Diagnostic Code 6847, amendment history to 71 FR 28586, May 2006) and § 4.87 (Diagnostic Code 6260, amendment history to 68 FR 25823, May 2003).

  9. 38 C.F.R. § 3.951 (preservation of disability ratings); § 3.957 (service connection); § 3.344 (stabilization of disability evaluations); § 3.105(e) and (i) (reduction procedure and predetermination hearings); § 3.155(b) (intent to file); § 4.25 (combined ratings table).

  10. 38 U.S.C. § 1115 (additional compensation for dependents); § 1155 (authority for schedule of ratings); § 5104B (higher-level review); § 5108 (supplemental claims); § 7105 (notice of disagreement).

  11. Department of Veterans Affairs, proposed rules revising the ear, nose, throat, audiology, and respiratory portions of the VA Schedule for Rating Disabilities (February 2022); 2026 Unified Agenda entry for RIN 2900-AQ72.

Frequently Asked Questions

The House passed H.R. 9237, the Take Care of America's Veterans Act, by voice vote on November 11, 2026. Section 108 of that bill would revise the rating criteria for sleep apnea and tinnitus. The bill is not law. It must pass the Senate and be signed by the President. The Senate has taken no floor action, and the Senate Veterans' Affairs Committee ranking member has stated opposition.

It is the applicability date in the House-passed text. Section 108(c)(1) applies the revised sleep apnea and tinnitus criteria to claims filed on or after October 1, 2026. The bill as introduced in June had read "after the date of the enactment of this Act." That phrase was struck and replaced during House consideration by the amendment printed in part B of House Report 119-749, which the House deemed adopted under H. Res. 1423.

Not for veterans already receiving them, and not yet for anyone. Nothing has changed as of November 15, 2026. VA continues to rate recurrent tinnitus at 10 percent under DC 6260 and sleep apnea requiring a CPAP at 50 percent under DC 6847. Section 108 is not law, and even if enacted, the revised criteria would have to be promulgated before VA could apply them.

No. Section 108(c)(2) bars using the revisions to reduce, discontinue, or otherwise adversely affect compensation in effect the day before enactment. Independently, 38 U.S.C. § 1155 provides that in no event shall a readjustment in the rating schedule cause a veteran's disability rating to be reduced unless an improvement in the disability is shown to have occurred, and 38 C.F.R. § 3.951(a) states the same rule in regulation. Because Section 108 directs revision of the schedule adopted under section 1155, that protection sits in the same provision the section relies on. An evaluation held continuously for 20 years or more carries further protection under § 3.951(b).

On the face of the House-passed text, yes. Section 108(c)(1) reaches claims filed on or after October 1, 2026, regardless of whether the law existed when the claim was filed. If the claim is granted and paying before enactment, the resulting compensation would be protected by Section 108(c)(2). If it is still pending when revised criteria take effect, the protection clause would have no compensation to protect. This is a legal question specific to your file and warrants an accredited representative.

Filing now does not place a claim outside Section 108, because the applicability date is October 1, 2026 and has already passed. That is not a reason to delay. Against the separate VA rulemaking, filing before a final rule takes effect does preserve the current criteria, and no final rule has been published. Filing also fixes the effective date that determines back pay. What remains true in either case is that an unsupported claim is a poor strategy, because a denial costs time that is not recoverable. Whether and when to file is a decision for an accredited representative, not for an article.

Grandfathering is not a term VA uses, but the protection veterans mean by it is real. Compensation already in payment is shielded from reduction on the basis of these revisions, both by Section 108(c)(2) and by 38 C.F.R. § 3.951(a). What the protection does not do is make an evaluation permanent. Reduction on other grounds, such as a routine future examination showing actual improvement, continues to operate. Note that the stabilization protections of 38 C.F.R. § 3.344(a) and (b) apply under § 3.344(c) to evaluations held at the same level for five years or more, and not to disabilities that have not stabilized and are likely to improve. The procedural requirements of § 3.105(e), including a rating proposing the reduction and 60 days to submit evidence, apply regardless of how long the evaluation has been held.

An existing 50 percent evaluation is protected. For claims reached by the provision, the prescription would no longer carry the rating. A syndrome asymptomatic on treatment would be 0 percent, incomplete relief on treatment would be 10 percent, treatment that is ineffective or unusable because of a comorbid condition without end-organ damage would be 50 percent, and end-organ damage would be 100 percent. There is no 30 percent grade in the new scale.

For claims reached by the provision, largely yes, with one exception. Section 108(b) bars a separate compensable rating for tinnitus except where it is diagnosed as associated with service-connected hearing loss that is otherwise noncompensable, in which case 10 percent applies. Tinnitus would remain a treatable condition in VA health care, and existing tinnitus evaluations are protected.

Section 108 does not say, but existing regulation is relevant. Under 38 C.F.R. § 3.155(b), where a complete application is received within one year of an intent to file, VA considers the complete claim filed as of the date the intent to file was received. On that rule, an intent to file received before October 1, 2026 followed by a complete claim within the year would arguably place the claim outside Section 108(c)(1). Section 108 uses the word "filed" without defining it, so whether VA would apply § 3.155(b) in implementing the statute is unresolved. If you hold an intent to file dated before October 1, 2026, raise it with an accredited representative.

A supplemental claim under 38 U.S.C. § 5108 is a claim, so one filed on or after October 1, 2026 could be reached by the provision even where the original claim predated that date. A higher-level review under 38 U.S.C. § 5104B and a notice of disagreement under § 7105, which initiates appellate review of a decision already made, continue an existing claim rather than starting a new one. The distinction could matter, and it is a legal question for an accredited representative.

The provision does not define the term. Whether it would reach pulmonary hypertension, cor pulmonale, refractory hypertension, cardiac arrhythmia, or other sequelae would be settled by the Secretary in the rulemaking the section directs. Anyone stating the answer with confidence at this stage is predicting rather than reporting.

There is no date. Section 108 directs the Secretary to revise the rating schedule and sets no deadline for doing so, and enactment alone would not change the criteria. Separately, VA's own 2022 proposed rule covering the same conditions remains pending, with the 2026 Unified Agenda projecting final action in April 2027 for RIN 2900-AQ72.

No. They are separate tracks toward similar outcomes. Section 108 would direct the change by statute, with an applicability date of October 1, 2026. VA's proposed rule, published February 2022 and still pending, would revise the same criteria by regulation, with an effective date set by the final rule. Either could alter future evaluations. Neither has taken effect.

Existing tinnitus evaluations are protected, so this concerns claims reached by the provision. For those, the absence of a standalone 10 percent changes the calculation under 38 C.F.R. § 4.25, which combines evaluations rather than adding them and then rounds the combined figure to the nearest multiple of 10. Because that rounding can move a combined evaluation across a threshold, and because additional compensation for dependents begins at 30 percent under 38 U.S.C. § 1115, the loss of a 10 percent grade can matter more than its size suggests.

Need help with your VA claim?

Get expert guidance and documentation from our licensed clinicians

Get Free Consultation
Content Standards
Written By
Military Disability Nexus Editorial Team

Educational Guidance and Evidence Research

View editorial standards
Reviewed For Clinical Accuracy
Military Disability Nexus Clinical Review Team

Clinical Integrity and Accuracy Review

View medical review policy

Originally published November 17, 2026 • Last updated November 16, 2026

About this article. This post is general educational and medical information published by the Military Disability Nexus clinical team. It is not legal advice, not individualized medical advice, and not a substitute for a personal evaluation by a licensed clinician or a consultation with an accredited representative. Reading it does not create a doctor-patient or attorney-client relationship. VA law and rating criteria change; some details may not reflect the most recent updates, and every claim is decided by the VA on its own facts – no outcome is promised or guaranteed. Military Disability Nexus is an independent medical-evidence provider and is not affiliated with, endorsed by, or acting on behalf of the U.S. Department of Veterans Affairs or any government agency. Free claims assistance is available from VA-accredited Veterans Service Organizations and county Veterans Service Officers; you can verify any representative's accreditation through the VA Office of General Counsel.